Recent Quotes
My Watchlist
Indicators
Investor Uprising 25
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

12.78 -0.21 (-1.62%)
Streaming Delayed Price Updated: 11:55 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
DNA Stock Earnings: Ginkgo Bioworks Holdings Misses EPS, Beats Revenue for Q2 2024
DNA stock results show that Ginkgo Bioworks Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Split
Ginkgo Bioworks stock is falling hard on Friday as DNA investors prepare to vote on a reverse stock split later this month. 
Via InvestorPlace
7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money?
Which of these 7 meme stocks are likely to punish investors and which are likely to provide free money? Read on to see. 
Via InvestorPlace
7 Sorry Biotech Stocks Set to Make Investors Sad
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell. 
Via InvestorPlace
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up. 
Via InvestorPlace
Topics Artificial Intelligence
DNA Stock: Ginkgo Bioworks Announces New Collaboration
Although Ginkgo Bioworks’ partnership with an agricultural innovator boosted DNA stock, the company still faces challenges. 
Via InvestorPlace
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?
A recovery plan is underway, but it isn't a slam dunk. 
Via The Motley Fool
3 Stocks to Avoid Like the Plague in 2024
Avoid these three stocks like the plague in 2024 to protect your portfolio from potential pitfalls and losses. 
Via InvestorPlace
3 High-Risk, Sky-High Reward Stocks to Buy for Under $1
These high-risk penny stocks may be cheap, but their low per-share pricing conceals unique tailwinds that could propel them higher. 
Via InvestorPlace
Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted
Ginkgo Bioworks stock is down, but this doesn't mean it's a bargain as Ginkgo Bioworks faces a serious delisting threat. 
Via InvestorPlace
7 F-Rated Stocks To Sell in July
If you're going to outperform even a basic index fund this year, you need to identify any F-rated stocks to sell in July. 
Via InvestorPlace
3 Biotech Stocks to Sell in July Before They Crash & Burn
While biotech stocks have potential to provide high returns, they are often overly dependent on drug approvals. Sell these before its too late 
Via InvestorPlace
Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally
 
Via Benzinga
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience. 
Via InvestorPlace
Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN), amidst a volatile market. 
Via Benzinga
Perion Layoffs 2024: What to Know About the Latest PERI Job Cuts
Perion Network layoffs are a hot topic on Wednesday as the company announces plans to cut 35 jobs its in search division due to Bing changes. 
Via InvestorPlace
Topics Workforce
Ginkgo Bioworks Layoffs Expand to 400 Job Cuts
Ginkgo Bioworks layoffs are coming for 400 of the company's employees as it seeks to reduce labor costs as part of a restructuring. 
Via InvestorPlace
Topics Workforce
Why Ginkgo Bioworks Stock Is Sinking Today
There was double trouble for this beaten-down biotech stock. 
Via The Motley Fool
Cathie Wood-Led Ark Invest Dumps $4.3M Worth Of Nvidia Shares Amid Rebound — Swoops Into Buy Stock Of This Netflix Rival
 
Via Benzinga
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
 
Via Benzinga
Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears
A 2024 coffee recall is in effect for products made by Snapchill LLC due to concerns of botulism from the FDA for hundreds of canned coffees. 
Via InvestorPlace
Ginkgo Bioworks Layoffs 2024: What to Know About the Latest DNA Job Cuts
Ginkgo Bioworks layoffs are a hot topic as the company prepares to cut 158 jobs this week with more headcount reductions coming next week. 
Via InvestorPlace
Topics Workforce
5-Year Fortune Forecast: 3 Penny Stocks Destined for Massive Gains
Here are three Penny stocks to buy if you have the patience and risk tolerance to wait for a potential payoff. 
Via InvestorPlace
7 Penny Stocks to Sell in June Before They Crash & Burn
It's way past time to dump these seven struggling penny stocks before things go from bad to worse for investors. 
Via InvestorPlace
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These pharma and biotech players could become long-term winners. 
Via The Motley Fool
3 Sorry Biotech Stocks to Sell in May While You Still Can
Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell. 
Via InvestorPlace
Ginkgo Bioworks Stock: Bull vs. Bear
This innovative biotechnology company hopes to turn things around. 
Via The Motley Fool
Should You Buy the Dip on Ginkgo Bioworks Stock?
Its vision is ambitious, but can it actually be made to work? 
Via The Motley Fool
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
You don't need to buy her picks, but it's worth understanding them. 
Via The Motley Fool
Cathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings. 
Via Benzinga
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.